Total Funding
1
3
Total FundingVenture - Series Unknown raised
Growth Score
-2 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
497085
Moksha8 is a pharmaceutical company providing therapeutics for the treatment of central nervous system and mental health disorders.
Acquired by 
ACINO
- Simba Gill: Founder & Chief Executive Officer, PresidentPast Role: Maxygen, Founder
Stig Pedersen: TitleExecutive ChairmanPast Role: MSI Methylation Sciences, Directors
About the Company
Moksha8 is a leading pharmaceutical company in Latin America. The company is partnered with Roche, Pfizer, BioCryst and Watson in Brazil and Mexico. Moksha8 was founded in 2007 by Simba Gill and TPG Biotechnology. Major investors include TPG Biotechnology and Montreux Equity Partners.
